Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04426435Phase 2Completed
Phase 2, randomised, double-blind trial (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Hemoglobin level at 4 weeks, White blood cell count at 4 weeks and 1 more. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04426435.